Large pharmaceutical firm Novartis confirmed that it is halting and investigating several clinical trial programs involving ...

As BIG Executive Summit participants reveal, biomanufacturing innovations often fail due to fragmented pathways for adoption, ...

Eli Lilly will acquire Merida Biosciences for up to $2.875 billion, gaining MER511, a Phase I therapy targeting ...

The organization is nurturing talent alongside NIBRT to fill the region’s many life science manufacturing jobs.

Human-in-the-loop models could provide a credible and scalable path forward for using agentic AI in biopharma commercial ...

Genentech will invest $750 million in a fill-finish facility in Oregon, reached a construction milestone in North Carolina, ...

Viral safety is a nonnegotiable regulatory expectation for biologic drug substances manufactured using mammalian cell culture ...

Learn how strategic CHO cell line development accelerates biologics timelines and supports clinical progression with flexible ...

Large-scale validation of regenerative medicine, especially based on cell therapies, may come from cell therapies developed ...

Argentine biotech firm Biosidus tripled its cell culture capacity with a $12.9 million expansion to boost biosimilar ...

An expert from CTMC told BioProcess International how recent projects in Houston speak to the city’s drive to become a ...

Earlier this week, it was confirmed that a $380 million partnership between Bristol Myers Squibb (BMS) and contract ...